Company

English: Research and Development at QIAGEN in Hilden, Germany. German: Forschung und Entwicklung bei QIAGEN in Hilden.Biotype Innovation was founded in 2015 by the biotechnology company Biotype Diagnostic GmbH in Dresden and the QIAGEN GmbH, headquartered in Hilden near Dusseldorf. The startup provides complex, fast, and efficient detection of molecular targets applicable in diverse life science areas.

The tests are mainly used in healthcare for fast detection of infectious diseases, and in personalized medicine. Future fields of application for the technology are pharmaceutical research, the pharmaceutical industry, as well as the monitoring of food.

At its headquarters in Dresden-Hellerau, Biotype Innovation develops testing methods and special reagents for molecular diagnostics, and markets them in the DACH-region (Germany, Austria, and Switzerland).

Quality Assurance

certification_badge_9001_13485Biotype Innovation is certified to meet DIN EN ISO 13485 and DIN EN ISO 9001 standards for the scope of sales, development, manufacturing and services of molecular tests for in-vitro diagnostic applications (ISO 13485:2016) and research and diagnostic applications (ISO 9001:2015).
The established quality management system ensures that the products and services meet all customer and regulatory requirements. Thereby, the company is able to provide its customers highest quality standards.

 

The certificates can be downloaded here:

ISO 13485 Certificate

ISO 9001 Certificate